Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/42182
metadata.artigo.dc.title: Structural features of coronavirus SARS-CoV-2 spike protein: targets for vaccination
metadata.artigo.dc.creator: Sternberg, Ariane
Naujokat, Cord
metadata.artigo.dc.subject: Coronavirus
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Spike protein
Protein structure
Receptor binding domain
Viral fusion protein
Angiotensin-converting enzyme 2 (ACE2)
Vaccination
Immune response
metadata.artigo.dc.publisher: Elsevier
metadata.artigo.dc.date.issued: Sep-2020
metadata.artigo.dc.identifier.citation: STERNBERG, A.; NAUJOKAT, C. Structural features of coronavirus SARS-CoV-2 spike protein: targets for vaccination. Life Sciences, [S.l.], v. 257, Sept. 2020.
metadata.artigo.dc.description.abstract: Various human pathogenic viruses employ envelope glycoproteins for host cell receptor recognition and binding, membrane fusion and viral entry. The spike (S) glycoprotein of betacoronavirus SARS-CoV-2 is a homotrimeric class I fusion protein that exists in a metastable conformation for cleavage by host cell proteases furin and TMPRSS2, thereby undergoing substantial structural rearrangement for ACE2 host cell receptor binding and subsequent viral entry by membrane fusion. The S protein is densely decorated with N-linked glycans protruding from the trimer surface that affect S protein folding, processing by host cell proteases and the elicitation of humoral immune response. Deep insight into the sophisticated structure of SARS-CoV-2 S protein may provide a blueprint for vaccination strategies, as reviewed herein.
metadata.artigo.dc.identifier.uri: https://www.sciencedirect.com/science/article/pii/S0024320520308079
http://repositorio.ufla.br/jspui/handle/1/42182
metadata.artigo.dc.language: en_US
Appears in Collections:FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.